Related Experiment Video
Updated: Jul 17, 2026

Localization of SUMO-modified Proteins Using Fluorescent Sumo-trapping Proteins
Published on: April 27, 2019
MEK-ERK is involved in SUMO-1 foci formation on apoptosis
Ryoko Utsubo-Kuniyoshi1, Yasuhito Terui, Yuko Mishima
1Division of Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan.
Abstract:
Small ubiquitin-related modifier (SUMO) modification appears to regulate the activity, intracellular localization, and stability of the targeted proteins. To explore the relationship among sumoylation, antitumor reagent, and apoptosis, we treated green fluorescence protein (GFP)-SUMO-1-overexpressed K562 cells (K562/GFP-SUMO-1) with mitoxantrone (MIT) as an antitumor reagent. By the treatment with MIT, GFP-SUMO-1 formed foci in nuclei. While by the treatment with a tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA), GFP-SUMO-1 located homogeneously in nuclei. When K562/GFP-SUMO-1 cells were treated with TPA plus MIT, GFP-SUMO-1 foci became larger and apoptosis was induced more than with MIT alone. The apoptosis induced by TPA plus MIT was prevented by blockage of GFP-SUMO-1 foci by small interfering RNA (siRNA) against SUMO-1. The formation of GFP-SUMO-1 foci was reduced by a MEK inhibitor U0126 or a nuclear export inhibitor leptomycin B, and endogenous SUMO-1 foci were reduced in K562 cells expressing the dominant-negative MEK1 mutant. These results suggest that the formation of SUMO-1 foci is regulated by the MEK-ERK pathway and may induce apoptosis.
Insights
Small ubiquitin-related modifier (SUMO)-1 foci formation in cancer cells, regulated by the MEK-ERK pathway, enhances apoptosis. Blocking these SUMO-1 foci prevents this enhanced cell death, suggesting a role in antitumor responses.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Small ubiquitin-related modifier (SUMO)ylation regulates protein activity, localization, and stability.
- Understanding SUMOylation's role in apoptosis and response to antitumor reagents is crucial.
Purpose of the Study:
- To investigate the relationship between SUMOylation, antitumor reagents, and apoptosis.
- To explore the regulation and function of SUMO-1 foci formation in cancer cells.
Main Methods:
- Overexpression of GFP-SUMO-1 in K562 cells.
- Treatment with mitoxantrone (MIT) and 12-O-tetradecanoylphorbol-13-acetate (TPA).
- Analysis of GFP-SUMO-1 localization, foci formation, and apoptosis induction; siRNA knockdown; MEK inhibitor treatment.
Main Results:
- Mitoxantrone treatment induced GFP-SUMO-1 foci formation in K562 cell nuclei.
- Co-treatment with TPA and MIT enhanced GFP-SUMO-1 foci size and induced greater apoptosis than MIT alone.
- Apoptosis induction was reduced by blocking GFP-SUMO-1 foci with SUMO-1 siRNA.
- Foci formation was modulated by MEK pathway inhibitors and nuclear export inhibitors.
Conclusions:
- SUMO-1 foci formation is regulated by the MEK-ERK pathway.
- SUMO-1 foci formation plays a role in inducing apoptosis, potentially enhancing antitumor effects.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Apoptosis
The Intrinsic Apoptotic Pathway
Caspases
MAPK Signaling Cascades
Cellular Injury V: Apoptosis and Autophagy
